(Q47273363)

13 January 2018

title

Ashkenazi Parkinson's disease patients with the LRRK2 G2019S mutation share a common founder dating from the second to fifth centuries (English)

1 reference

13 January 2018

1 reference

4

1 reference

13 January 2018

Nir Giladi

series ordinal

3

object named as

Nir Giladi

1 reference

13 January 2018

5

Avi Orr-Urtreger

1 reference

13 January 2018

1

Anat Bar-Shira

1 reference

13 January 2018

author name string

Carolyn M Hutter

series ordinal

2

1 reference

13 January 2018

publication date

13 March 2009

1 reference

13 January 2018

published in

Neurogenetics

1 reference

13 January 2018

volume

10

1 reference

13 January 2018

issue

4

1 reference

13 January 2018

page(s)

355-358

1 reference

13 January 2018

https://scigraph.springernature.com/pub.10.1007/s10048-009-0186-0

exact match

0 references

cites work

The carrier frequency of the BRCA1 185delAG mutation is approximately 1 percent in Ashkenazi Jewish individuals

1 reference

12 December 2020

Estimating the age of rare disease mutations: the example of Triple-A syndrome.

1 reference

12 December 2020

Haplotype analysis of Lrrk2 R1441H carriers with parkinsonism

1 reference

12 December 2020

A founding LRRK2 haplotype shared by Tunisian, US, European and Middle Eastern families with Parkinson's disease

1 reference

12 December 2020

Identification and haplotype analysis of LRRK2 G2019S in Japanese patients with Parkinson disease

1 reference

12 December 2020

The ancestry of LRRK2 Gly2019Ser parkinsonism

1 reference

12 December 2020

Lrrk2 R1441C parkinsonism is clinically similar to sporadic Parkinson disease.

1 reference

12 December 2020

The G6055A (G2019S) mutation in LRRK2 is frequent in both early and late onset Parkinson's disease and originates from a common ancestor

1 reference

12 December 2020

LRRK2 G2019S as a cause of Parkinson's disease in Ashkenazi Jews.

1 reference

12 December 2020

LRRK2 G2019S in families with Parkinson disease who originated from Europe and the Middle East: evidence of two distinct founding events beginning two millennia ago.

1 reference

12 December 2020

LRRK2 haplotype analyses in European and North African families with Parkinson disease: a common founder for the G2019S mutation dating from the 13th century

1 reference

12 December 2020

Identification of a novel LRRK2 mutation linked to autosomal dominant parkinsonism: evidence of a common founder across European populations

1 reference

12 December 2020

New estimates of intergenerational time intervals for the calculation of age and origins of mutations

1 reference

12 December 2020

Molecular pathogenesis of Parkinson disease

1 reference

12 December 2020

LRRK2 mutations in patients with Parkinson's disease from Peru and Uruguay

1 reference

12 December 2020

LRRK2G2019S as a Cause of Parkinson's Disease in North African Arabs

1 reference

12 December 2020

The 185delAG BRCA1 mutation originated before the dispersion of Jews in the diaspora and is not limited to Ashkenazim

1 reference

12 December 2020

Clinical and positron emission tomography of Parkinson's disease caused by LRRK2.

1 reference

12 December 2020

Could the 185delAG BRCA1 mutation be an ancient Jewish mutation?

1 reference

12 December 2020

High prevalence of LRRK2 mutations in familial and sporadic Parkinson's disease in Portugal

1 reference

12 December 2020

Cross-cultural estimation of the human generation interval for use in genetics-based population divergence studies

1 reference

12 December 2020

Accounting for decay of linkage disequilibrium in haplotype inference and missing-data imputation

1 reference

12 December 2020

Phenotype, genotype, and worldwide genetic penetrance of LRRK2-associated Parkinson's disease: a case-control study

1 reference

12 December 2020

The LRRK2 G2019S mutation in Ashkenazi Jews with Parkinson disease: is there a gender effect?

1 reference

12 December 2020

G2019S dardarin substitution is a common cause of Parkinson's disease in a Portuguese cohort

1 reference

12 December 2020

LRRK2 Gly2019Ser penetrance in Arab-Berber patients from Tunisia: a case-control genetic study

1 reference

12 December 2020

Analysis of Parkinson disease patients from Portugal for mutations in SNCA, PRKN, PINK1 and LRRK2

1 reference

12 December 2020

Prevalence of Parkinson's disease in Europe: A collaborative study of population-based cohorts. Neurologic Diseases in the Elderly Research Group

1 reference

12 December 2020

10.1007/S10048-009-0186-0

Identifiers

DOI

1 reference

13 January 2018

PubMed ID

19283415

1 reference

13 January 2018